SAGE Latest News, Press Relases and Analysis

All

Press Releases

5 months ago - By: The Motley Fool

Sage (SAGE) Q2 Revenue Jumps 264%

5 months ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SUPN

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

5 months ago - By: Sage Therapeutics, Inc.

Sage Therapeutics Announces Second Quarter 2025 Financial Results

5 months ago - By: Supernus Pharmaceuticals, Inc. - Mentions: SUPN

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

5 months ago - By: Benzinga

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock

6 months ago - By: Benzinga

Deep Dive Into Sage Therapeutics Stock: Analyst Perspectives (4 Ratings)

5 months ago - By: Biogen Inc. - Mentions: BIIB

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

5 months ago - By: Kahn Swick & Foti, LLC

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

6 months ago - By: Rowley Law PLLC - Mentions: SUPN

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

5 months ago - By: Investor's Business Daily - Mentions: ACAD SLNO HRMY NBIX ...

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

5 months ago - By: Halper Sadeh LLC - Mentions: COEP AVDX

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

6 months ago - By: FN Media Group LLC - Mentions: NYSE CMPS MNMD ATAI

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

6 months ago - By: Brodsky & Smith LLC - Mentions: VERV CTLP NYSE LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

6 months ago - By: Halper Sadeh LLC - Mentions: GNTY CHTR TASK

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, CHTR, SAGE, TASK on Behalf of Shareholders

6 months ago - By: Phathom Pharmaceuticals - Mentions: PHAT

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

6 months ago - By: Stocktwits - Mentions: SUPN BIIB JPM

Sage Therapeutics Stock: JPMorgan Sees 8% Downside After Supernus Buyout Terms

6 months ago - By: Kahn Swick & Foti, LLC

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

6 months ago - By: Yahoo Finance - Mentions: BIIB SUPN

H.C. Wainwright sees potential competition for Sage from Biogen

6 months ago - By: Halper Sadeh LLC - Mentions: VERV CTLP SOAR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

6 months ago - By: Brodsky & Smith LLC - Mentions: VERV CTLP SOAR LLY ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

6 months ago - By: Yahoo Finance - Mentions: AGEN HON ITGR TTEK ...

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

6 months ago - By: Yahoo Finance - Mentions: CRCL SF HNGE ATAT ...

How to get a $40,000 personal loan

6 months ago - By: Yahoo Finance - Mentions: BIIB SUPN

SAGE THERAPEUTICS INC (SAGE) Stock News

SAGE Latest News, Press Relases and Analysis

Sage (SAGE) Q2 Revenue Jumps 264%

Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics

Sage Therapeutics Announces Second Quarter 2025 Financial Results

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Sage Therapeutics, Inc. Tender Offer

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock

Deep Dive Into Sage Therapeutics Stock: Analyst Perspectives (4 Ratings)

ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Sage Therapeutics, Inc.

Acadia Emerges From Behind The Scenes With A Potential $12 Billion Opportunity

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GNTY, CHTR, SAGE, TASK on Behalf of Shareholders

Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary

Sage Therapeutics Stock: JPMorgan Sees 8% Downside After Supernus Buyout Terms

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc. - SAGE

H.C. Wainwright sees potential competition for Sage from Biogen

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)

Agenus Inc. (AGEN) Surges After Zydus Agreement, Analysts Upbeat on Stock

How to get a $40,000 personal loan

Supernus makes depression drug play with $795m Sage buyout